Surgepays Inc (SURG)
Official siteCOMMUNICATION SERVICES • TELECOM SERVICES • NASDAQ
Market Cap: $8.67M
Last updated: Nov 17, 2026 at 4:44 PM ET
Surgepays Inc (SURG) Statistics
Surgepays (SURG) has a market cap of $8.67M and an enterprise value of $23.98M. Its share count is up 30.33% from a year earlier. Revenue grew 83.91% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 176.57% above the market cap, as debt exceeds cash.
| Market Cap | $8.67M |
|---|---|
| Enterprise Value | $23.98M |
| Latest price (Nov 17, 2026) | $0.14 |
Key Dates
The next earnings report is expected on Nov 17, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Nov 17, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 14, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 93.17% over 52 weeks and trades 6.67% below its 50-day average.
| Beta (1Y) | 0.30 |
|---|---|
| 52-Week Change | -93.17% |
| 1-Month Change | +17.09% |
| 3-Month Change | -44.10% |
| 6-Month Change | -73.91% |
| 5-Year Change | -96.71% |
| Total Return (1Y) | -93.17% |
| Total Return (3Y CAGR) | -71.48% |
| Total Return (5Y CAGR) | -43.43% |
| Max Drawdown (1Y) | -94.26% |
| Max Drawdown (3Y) | -98.70% |
| Sharpe Ratio (1Y) | -2.14 |
| Correlation with SPY (1Y) | 0.03 |
| 50-Day Average | $0.15 |
| 200-Day Average | $0.44 |
| 52-Week Range | $0.11 to $2.08 |
| RSI (14 Days) | 43.1 |
| Average Volume (20 Days) | 5.66M |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 0.19x current liabilities.
| Current Ratio | 0.19x |
|---|---|
| Quick Ratio | 0.18x |
| Interest Coverage | 31.84x |
Returns and Efficiency
Return on invested capital is 755.14% over the last 12 months.
| Return on Assets (ROA) | -347.61% |
|---|---|
| Return on Invested Capital (ROIC) | 755.14% |
| Asset Turnover | 5.48x |
| Inventory Turnover | 270.20x |
| Receivables Turnover | 19.52x |
| Cash Conversion Cycle | -45 days |
Scores
SURG has an Altman Z-Score of -22.02, in the distress zone below 1.81, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -22.02 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 3 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue was $67.06M over the last 12 months.
| Revenue | $67.06M |
|---|---|
| Revenue Growth (YoY) | +83.91% |
| Gross Profit | -$13.11M |
| Operating Income | -$32.53M |
| Pretax Income | -$32.11M |
| Net Income | -$32.11M |
| EBIT | -$28.72M |
| Reported EPS (TTM) | -$1.71 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
| Cash and Equivalents | $2.38M |
|---|---|
| Total Debt | $17.69M |
| Net Debt | $15.31M |
| Net Debt Per Share | $0.59 |
| Working Capital | -$21.30M |
| Shareholder Equity | -$20.69M |
| Tangible Book Value | -$21.19M |
| Total Assets | $9.24M |
| Total Liabilities | $29.99M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $2.63M of capital spending, operating cash flow left -$18.02M of free cash flow.
| Operating Cash Flow | -$15.39M |
|---|---|
| Capital Expenditures | $2.63M |
| Free Cash Flow | -$18.02M |
| FCF Per Share | -$0.29 |
| Depreciation and Amortization | $995.05K |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -48.51%, against a 5-year average of -25.20%.
| Gross Margin | -19.56% |
|---|---|
| Operating Margin | -48.51% |
| Pretax Margin | -47.89% |
| Net Margin | -47.89% |
| EBIT Margin | -42.82% |
| FCF Margin | -26.88% |
| Gross Margin (5Y Average) | 1.41% |
| Operating Margin (5Y Average) | -25.20% |
| Net Margin (5Y Average) | -30.09% |
Growth
Revenue fell 22.32% a year over 3 years.
| Revenue Growth (3Y CAGR) | -22.32% |
|---|---|
| Revenue Growth (5Y CAGR) | +0.92% |
Stock Splits
The last split was a 1-for-50 reverse split on Nov 2, 2021.
| Last Split Date | Nov 2, 2021 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:50 |
Peer Position
Against 11 similar companies, SURG has the highest ROIC.
ROICPeer median -0.58%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -1.89%
| ROIC | 755.14% vs -0.58% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | +83.91% vs -1.89% median |
Analyst Forecast
Consensus estimates put revenue growth at 10.93% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | +10.93% |
|---|
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About SURG
What is SURG's market cap?
Surgepays has a market cap of $8.67M. Its enterprise value, which adds debt and subtracts cash, is $23.98M.
How many shares of SURG are outstanding?
Surgepays has 25.92M shares outstanding. The count is up 30.33% from a year earlier.
Does SURG pay a dividend?
No. Surgepays does not pay a dividend.
How much debt does SURG have?
Surgepays has $17.69M of total debt and $2.38M of cash and equivalents, a net debt position of $15.31M.
SURG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors